2.895

12.16% 0.305

Quanterix Corp (QTRX)

Overview News Price History Option Chain Financials Discussions Forecast

Quanterix Corp stock is traded at $2.895, with a volume of 1.10M. It is up +12.16% in the last 24 hours and down -24.84% over the past month. Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Previous Close:

$2.59

Open:

$2.79

24h Volume:

1.10M

Relative Volume:

1.11

Market Cap:

$136.91M

Revenue:

$144.98M

Net Income/Loss:

$-104.19M

P/E Ratio:

-1.2231

EPS:

-2.367

Net Cash Flow:

$-82.90M

1W Performance:

+20.04%

1M Performance:

-24.84%

6M Performance:

-49.57%

1Y Performance:

-36.43%

1-Day Range:

$2.655

$2.9211

1-Week Range:

$2.36

$3.13

52-Week Range:

$2.15

$8.77

Quanterix Corp Stock (QTRX) Company Profile

Name

Quanterix Corp

Sector

Healthcare (1089)

Industry

Medical Devices (141)

Phone

617-301-9400

Address

900 MIDDLESEX TURNPIKE, BILLERICA, MA

Employee

450

Twitter

@QuanterixSimoa

Next Earnings Date

2026-08-06

Latest SEC Filings

QTRX's Discussions on Twitter

Compare QTRX vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
QTRX Quanterix Corp	2.895	122.49M	144.98M	-104.19M	-82.90M	-2.367
ABT Abbott Laboratories	109.67	192.51B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	331.78	130.11B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	90.57	116.83B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	51.48	75.11B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	90.68	52.80B	6.30B	1.07B	1.09B	1.8406

Quanterix Corp Stock (QTRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-11-25	Downgrade	Canaccord Genuity	Buy → Hold
Feb-01-24	Initiated	Scotiabank	Sector Outperform
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform
May-23-23	Upgrade	Goldman	Neutral → Buy
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Mar-02-22	Upgrade	Goldman	Sell → Neutral
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell

View All

Quanterix Corp Stock (QTRX) Latest News

09:29 AM

QTRX Maintains Rating by Canaccord Genuity -- Price Target Lowered to $3.00 - GuruFocus

09:29 AM

08:39 AM

Quanterix (NASDAQ:QTRX) Price Target Cut to $3.00 by Analysts at Canaccord Genuity Group - MarketBeat

08:39 AM

08:10 AM

Canaccord cuts Quanterix stock price target on weak Q2 results - Investing.com

08:10 AM

Aug 16, 2026

Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - sharewise.com

Aug 16, 2026

Aug 15, 2026